Related Experiment Video
Updated: Jun 23, 2026

Morphometric Protocol for the Objective Assessment of Blastocyst Behavior During Vitrification and Warming Steps
Published on: February 28, 2019
Lipid Accumulation in Blastocystis Increases Cell Damage in Co-Cultured Cells
Chen-Chieh Liao1, Chun-Hsien Chen1,2, Jyh-Wei Shin1,3
1Department of Parasitology, Institute of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.
Abstract:
Blastocystis hominis is an intestinal protozoan that is often neglected, despite causing abdominal pain and diarrhea. Previous research has demonstrated that lipids can be synthesized by B. hominis or can accumulate in growth medium, but their function and mechanisms in the pathogenesis of Blastocystis remain unclear. Our study found that lipid-rich Blastocystis ST7-B can increase inflammation and disrupt Caco-2 cells more than the same parasite without the lipovenoes supplement. Additionally, the cysteine protease of Blastocystis, a virulence factor, is upregulated and has higher activity in lipid-rich Blastocystis. In order to better understand the effects of lipids on Blastocystis pathogenesis, we treated lipid-lowering pravastatin during Blastocystis ST7-B culturing with a lipovenoes supplement, which decreased the lipid levels of the Blastocystis and reduced the Blastocystis-induced inflammation and cell disruption of Caco-2 cells. We also analyzed the fatty acid composition and possible synthesis pathway in Blastocystis ST7-B, finding significantly higher ratios of arachidonic acid, oleic acid, and palmitic acid than in the other lipid components in lipid-rich Blastocystis ST7-B. These results suggest that lipids play a significant role in the pathogenesis of Blastocystis and provide important information on the molecular mechanisms of and potential treatments for Blastocystis infection.
Insights
Lipids significantly worsen Blastocystis hominis infections by increasing inflammation and parasite virulence. Lowering lipids with pravastatin reduced these harmful effects, suggesting new treatment strategies for Blastocystis infections.
Area of Science:
- Microbiology
- Parasitology
- Molecular Biology
Background:
- Blastocystis hominis is an underappreciated intestinal protozoan.
- Lipid accumulation in B. hominis is known, but its role in pathogenesis is unclear.
Purpose of the Study:
- To investigate the role of lipids in Blastocystis hominis pathogenesis.
- To explore potential therapeutic interventions targeting lipid metabolism.
Main Methods:
- Culturing Blastocystis ST7-B with and without lipid supplements.
- Assessing parasite-induced inflammation and Caco-2 cell disruption.
- Measuring cysteine protease activity.
- Treating cultures with the lipid-lowering drug pravastatin.
- Analyzing fatty acid composition.
Main Results:
- Lipid-rich Blastocystis ST7-B exhibited increased inflammation and Caco-2 cell disruption.
- Lipid-rich parasites showed upregulated cysteine protease activity.
- Pravastatin treatment reduced lipid levels, inflammation, and cell damage.
- Key fatty acids like arachidonic, oleic, and palmitic acids were elevated in lipid-rich Blastocystis.
Conclusions:
- Lipids play a critical role in Blastocystis hominis pathogenesis.
- Targeting lipid metabolism, for example with pravastatin, offers a potential therapeutic strategy.
- Understanding lipid pathways provides insights into Blastocystis infection mechanisms.

